Microbial transformation has been considered a powerful tool to modify the structures of natural bioactive substrates owing to its generally highly regio and stereo selective, simple, safe, environment friendly and relatively mild reaction conditions.1, 2, 3 A wide variety of new derivatives of natural products can be obtained by oxidation,4 hydrolysis,5 isomerization, hydroxylation, esterification,6 phosphorylation7 and glycosylation8 employing different conversion systems. Tenvermectins A and B are a kind of 16-membered macrocyclic lactone antibiotics isolated from the fermentation broth of genetically engineered strain Streptomyces avermitilis MHJ1011 with potent insecticidal properties.9, 10 Aiming at obtaining new target derivatives with improved insecticidal activity and lower toxicity, we carried out the transformation study of tenvermectins A and B by several microbial strains and no positive results were obtained. Inspired by literature,11, 12 we examined the microbial conversion of tenvermectins A and B by Saccharopolyspora erythraea ATCC 11635. This led to the isolation and identification of two new tenvermectin analogs, 4″-O-glucosyl tenvermectin A (1) and 4″-O-glucosyl tenvermectin B (2) (Figure 1). In this paper, we describe the microbial conversion of tenvermectins A and B, as well as the isolation, structural elucidation, nematocidal and acarcidal activity of the two new compounds.

Figure 1
figure 1

Structures and key HMBC correlations of compounds 1 and 2.

The strain S. erythraea, purchased from the American Type Culture Collection (Manassas, VA, USA) under the accession number ATCC 11635, was maintained on a yeast-malt-starch (YMS) plate. Three 250 ml Erlenmeyer flasks, each containing 40 ml of seed medium consisted of peptone (Bei Jing Ao Bo Xing, Beijing, China) 0.3%, yeast extract (Bei Jing Ao Bo Xing) 0.2%, beef extract (Bei Jing Ao Bo Xing) 0.1% and glucose (Bei Jing Ao Bo Xing) 1%, pH 7.0, were inoculated with freshly obtained S. erythraea cultured from the YMS plate and cultivated on a rotary shaker with 250 r.p.m. at 28 °C for 40 h. Then, this culture was employed as an inoculum (5%, v/v) for sixty 250 ml Erlenmeyer flasks containing 50 ml of medium comprising dextrose (Bei Jing Ao Bo Xing) 4.4%, beef extract 0.5%, peptone 0.6%, yeast extract 0.4%, tryptone (Oxoid, Basingstoke, England) 0.3%, soybean flour (Ningbo Beilun Jiangnan Grease, Ningbo, China) 1.1%, NaCl 0.15% and K2HPO4 0.05% (pH adjusted to 7.2 prior to sterilization). All the media were sterilized at 121 °C for 20 min. The cultivation was performed on a rotary shaker at 28 °C with 250 r.p.m. After 24 h, the mixture of tenvermectins A and B solution (20 mg of tenvermectins A and B dissolved in 800 μl MeOH) was added to the growing culture and the incubation was continued for a further 120 h.

After a further 5-day incubation, the final 3 l of conversion broth was pooled and filtered. The mycelia cake was extracted with ethanol (1 l). The ethanol extract was then concentrated under reduced pressure to 150 ml at 45 °C and subsequently extracted three times using an equal volume of EtOAc. The combined organic layer was evaporated under reduced pressure to give 5 g of crude residue. The crude residue was applied on a silica-gel column (Qingdao Haiyang Chemical Group, Qingdao, China; 100–200 mesh) eluted with a stepwise gradient of CHCl3/MeOH (100:0–70:30, v/v) to afford two fractions (I and II) based on the TLC profiles. TLC was performed on silica-gel plates (HSGF254, Yantai Chemical Industry Research Institute, Yantai, China), with solvent system of CHCl3/MeOH (9:1). The developed TLC plates were observed under a UV lamp at 254 nm or by heating after spraying with sulfuric acid/ethanol, 5:95 (v/v). The fraction II (220 mg) eluted with CHCl3/MeOH (85:15, v/v) was subjected to a Sephadex LH-20 gel (GE Healthcare, Glies, UK) column using CHCl3/MeOH (50:50, v/v) as eluents and detected by TLC profiles to obtain two subfractions. The second subfraction was further isolated with semipreparative HPLC (Agilent 1100, Zorbax SB-C18, 5 μm, 250 × 9.4 mm inner diameter; 1.5 ml min−1; 245 nm; Agilent, Palo Alto, CA, USA) eluting with a MeOH/CH3CN/H2O mixture (45:45:10) to give compounds 1 (tR 16.1 min, 28.6 mg) and 2 (tR 19.9 min, 27.4 mg). Optical rotation values were measured on a Perkin-Elmer 341 polarimeter (Perkin-Elmer, Fremont, CA, USA). UV spectra were recorded on a Varian CARY 300 BIO spectrophotometer (Varian, Palo Alto, CA, USA), and the IR spectra were conducted on a Nicolet Magna FT-IR 750 spectrometer (Nicolet Magna, Madison, WI, USA); 1H and 13C NMR spectra were measured on a Bruker DRX-400 (400 MHz for 1H and 100 MHz for 13C) spectrometer (Bruker, Rheinstetten, Germany). The ESI-MS and HRESI-MS data were determined on a Q-TOF Micro LC-MS-MS mass spectrometer (Waters, Milford, MA, USA).

The physicochemical properties of 1 and 2 are summarized in Table 1. The molecular formulas of 1 and 2 were determined to be C51H78O19 and C52H80O19, respectively, by HRESI-MS analysis, and their molecular masses were 162 mass units higher than the corresponding parent compounds, tenvermectins A and B, respectively. 1H and 13C NMR data for 1 and 2 were shown in Table 2. The NMR data of 1 and 2 were similar to those of tenvermectins A and B except of the additional sugar moiety revealed by the anomeric proton signals at δH 4.46 (1H, d, J=7.6 Hz) in 1 and at δH 4.46 (1H, d, J=7.5 Hz) in 2. The chemical shift assignments and sugar linkage sites were determined by 1H–1H COSY, HMQC and HMBC experiments. By comparison of the chemical shifts and coupling constants of the additional sugar moiety in 1 and 2 with those of β-d-glucose residue that was contained in 2(R)-3-(4′-O-β-d-glucopyranosyl-3′-methoxyphenyl)propane-1,2-diol13 and 6-hydroxy-2,2-dimethyl-3,4-dihydro-2H-naphtho[1,2-b]pyran-5-O-β-d-glucopyranoside,14 it was shown that the additional sugar moiety in 1 and 2 were β-d-glucose. The position of the glucosyl linkage in 1 and 2 were supported by the HMBC correlation (Figure 1) between the anomeric proton H-1‴ and C-4″. The assignment of the terminal glucose residue in 1 and 2 was further confirmed by the fact that the strain S. erythraea ATCC 11635 could transform the avermectin and ivermectin to the corresponding 4″-O-glucosyl derivatives.12 Therefore, the structures of 1 and 2 (Figure 1) were identified as 4″-O-glucosyl tenvermectin A and 4″-O-glucosyl tenvermectin B, respectively.

Table 1 Physicochemical properties of 1 and 2
Table 2 1H and 13C NMR dataa of compounds 1 and 2

The nematocidal and acaricidal activity of 1 and 2 against Bursaphelenchus xylophilus and Tetranychus cinnabarinus, respectively, reared in the laboratory were evaluated according to our reported paper.9, 10 In addition, for comparison, the nematocidal and acaricidal activity of their parent compounds, tenvermectins A and B, were examined. The bioassays were performed simultaneously on three replicates for each concentration. The bioassay results (Table 3) demonstrated that the two bioconversion products 1 and 2 showed almost the same or a slightly weaker nematocidal activity (LC50s: 1, 6.7984 mg l−1; 2, 5.7980 mg l−1) than tenvermectins A and B against third-instar larvae of B. xylophilus. In addition, compounds 1 and 2 exhibited acaricidal activity against adult mites of T. cinnabarinus with LC50 values of 0.0156 and 0.0113 mg l−1, respectively, nearly as potent as their parent compounds.

Table 3 Biological activity of compounds 1 and 2 against B. xylophilus and T. cinnabarinus